Clinical Trials | November 29, 2021
AMPATH launches its pathology laboratory in Mumbai
The company has has 10 existing labs in India
The company has has 10 existing labs in India
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
A first for the Asian market, addressing the health spends needs of over 200 million households.
The week-long campaign received a record 17.691 pledges
Subscribe To Our Newsletter & Stay Updated
